Similar articles for PMID: 21774728

Year	Number of Results
1995	1
1996	1
1998	3
2000	1
2001	2
2002	2
2003	6
2004	2
2005	7
2006	4
2007	2
2008	4
2009	1
2010	1
2011	6
2012	3
2013	3
2014	2
2016	1
2024	0

1

Takeuchi S, Nawashiro H. Takeuchi S, et al. N Engl J Med. 2011 Jul 21;365(3):276-7; author reply 277-8. doi: 10.1056/NEJMc1103354. N Engl J Med. 2011. PMID: 21774728 No abstract available.

2

NFKBIA deletion in glioblastomas.

Idbaih A, Marie Y, Sanson M. Idbaih A, et al. N Engl J Med. 2011 Jul 21;365(3):277; author reply 277-8. doi: 10.1056/NEJMc1103354. N Engl J Med. 2011. PMID: 21774727 No abstract available.

3

NFKBIA deletion in glioblastomas.

Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ, Chandler JP, Yu IL, Carro MS, Dai F, Tagge MJ, Ferrarese R, Bredel C, Phillips HS, Lukac PJ, Robe PA, Weyerbrock A, Vogel H, Dubner S, Mobley B, He X, Scheck AC, Sikic BI, Aldape KD, Chakravarti A, Harsh GR 4th. Bredel M, et al. N Engl J Med. 2011 Feb 17;364(7):627-37. doi: 10.1056/NEJMoa1006312. Epub 2010 Dec 22. N Engl J Med. 2011. PMID: 21175304 Free PMC article.

4

Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.

Zhao Z, Zhong X, Wu T, Yang T, Chen G, Xie X, Wei Y, Ye M, Zhou Y, Du Z. Zhao Z, et al. Int J Mol Med. 2014 Nov;34(5):1233-40. doi: 10.3892/ijmm.2014.1932. Epub 2014 Sep 12. Int J Mol Med. 2014. PMID: 25215581 Free PMC article.

5

Alteration in NFKBIA and EGFR in glioblastoma multiforme.

Komotar RJ, Starke RM, Connolly ES, Sisti MB. Komotar RJ, et al. Neurosurgery. 2011 Jun;68(6):N14-5. doi: 10.1227/01.neu.0000398206.71573.50. Neurosurgery. 2011. PMID: 21778941 Review. No abstract available.

6

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.

Patanè M, Porrati P, Bottega E, Morosini S, Cantini G, Girgenti V, Rizzo A, Eoli M, Pollo B, Sciacca FL, Pellegatta S, Finocchiaro G. Patanè M, et al. Mol Cancer. 2013 Dec 11;12:160. doi: 10.1186/1476-4598-12-160. Mol Cancer. 2013. PMID: 24330732 Free PMC article.

7

In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.

Robe PA, Bentires-Alj M, Bonif M, Rogister B, Deprez M, Haddada H, Khac MT, Jolois O, Erkmen K, Merville MP, Black PM, Bours V. Robe PA, et al. Clin Cancer Res. 2004 Aug 15;10(16):5595-603. doi: 10.1158/1078-0432.CCR-03-0392. Clin Cancer Res. 2004. PMID: 15328202 Free article.

8

ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.

Huang L, Verstrepen L, Heyninck K, Wullaert A, Revets H, De Baetselier P, Beyaert R. Huang L, et al. Oncogene. 2008 Oct 16;27(47):6131-40. doi: 10.1038/onc.2008.208. Epub 2008 Jul 14. Oncogene. 2008. PMID: 18622428

9

Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo.

Nogueira L, Ruiz-Ontañon P, Vazquez-Barquero A, Lafarga M, Berciano MT, Aldaz B, Grande L, Casafont I, Segura V, Robles EF, Suarez D, Garcia LF, Martinez-Climent JA, Fernandez-Luna JL. Nogueira L, et al. Oncogene. 2011 Aug 11;30(32):3537-48. doi: 10.1038/onc.2011.74. Epub 2011 Mar 21. Oncogene. 2011. PMID: 21423202

10

Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.

Thomas RK, Sos ML, Zander T, Mani O, Popov A, Berenbrinker D, Smola-Hess S, Schultze JL, Wolf J. Thomas RK, et al. Clin Cancer Res. 2005 Nov 15;11(22):8186-94. doi: 10.1158/1078-0432.CCR-05-0224. Clin Cancer Res. 2005. PMID: 16299251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

48 results

Results by year